ACS Applied Materials & Interfaces · 2022 · 55 citations · 21 references
MedicineCancer BiologyOncologyBiomaterialsCancer PharmacologyMolecular OncologyCancer NanomedicineInorganic NanoparticlesNanomedicineNanoparticle DesignPhotodynamic TherapyReactive Oxygen SpeciesCovalent Organic FrameworksFenton ReactionFenton-like ReactionsImmunogenic Cell Death InductionMultifunctional NanomaterialsMultifunctional NanoplatformsSinglet Oxygen FormationSinglet Oxygen Generation
Reactive oxygen species (ROS)-based cancer treatments have attracted much attention in recent years. However, most patients respond poorly to the monotypic ROS during these treatments. In this work, a multiple ROS-based cancer immunotherapy synergistic strategy has been developed to enhance the therapeutic effect of cancer. We prepare a three-dimensional covalent organic framework (3D COF-TATB), and embed copper ions (Cu2+) into the skeleton to obtain multifunctional nanomaterial, 3D Cu@COF-TATB. In this system, porphyrins in 3D COF-TATB serve not only as the photosensitizer for photodynamic process to produce singlet oxygen(1O2), but also as the binding sites to complex with Cu2+. Cu2+ can be reduced by the GSH to generate Cu+ to produce hydroxyl radical (•OH) through the Fenton-like reaction. Moreover, the generated multiple types of ROS induce the immunogenic cell death (ICD) of cancer cells to improve the immunogenicity and further activate an immune response for attacking the tumor. Combining with the immunoblocking inhibitor (aPD-1), 3D Cu@COF-TATB can effectively inhibit the tumor growth. This work will provide a guidance for multimodal cancer therapy in future clinical treatment settings.
21
3D Porphyrin-Based Covalent Organic Frameworks
Guiqing Lin, Huimin Ding, Rufan Chen et al. · Journal of the American Chemical Society · 2017 · 501 citations
Reactive Oxygen Species Regulate Activation-Induced T Cell Apoptosis
David A. Hildeman, Tom Mitchell, T. Kent Teague et al. · Immunity · 1999 · 484 citations · Full text
Endoplasmic Reticulum Targeting to Amplify Immunogenic Cell Death for Cancer Immunotherapy
Hongzhang Deng, Zijian Zhou, Weijing Yang et al. · Nano Letters · 2020 · 361 citations